Literature DB >> 26351891

Robotic Whipple Procedure for Pancreatic Cancer: The Moffitt Cancer Center Pathway.

Omar M Rashid1, John E Mullinax, Jose M Pimiento, Kenneth L Meredith, Mokenge P Malafa.   

Abstract

BACKGROUND: Resection of malignancies in the head and uncinate process of the pancreas (Whipple procedure) using a robotic approach is emerging as a surgical option. Although several case series of the robotic Whipple procedure have been reported, detailed descriptions of operative techniques and a clear pathway for adopting this technology are lacking.
METHODS: We present a focused review of the procedure as it applies to pancreatic cancer and describe our clinical pathway for the robotic Whipple procedure used in pancreatic cancer and review the outcomes of our early experience. A systematic review of the literature is provided, focusing on the indications, variations in surgical techniques, complications, and oncological results of the robotic Whipple procedure.
RESULTS: A clinical pathway has been defined for preoperative training of surgeons, the requirements for hospital privileges, patient selection, and surgical techniques for the robotic Whipple procedure. The robotic technique for managing malignant lesions of the pancreas head is safe when following well-established guidelines for adopting the technology. Preliminary data demonstrate that perioperative convalescence may exceed end points when compared with the open technique.
CONCLUSIONS: The robotic Whipple procedure is a minimally invasive approach for select patients as part of multidisciplinary management of periampullary lesions in tertiary centers where clinicians have developed robotic surgical programs. Prospective trials are needed to define the short- and long-term benefits of the robotic Whipple procedure.

Entities:  

Mesh:

Year:  2015        PMID: 26351891     DOI: 10.1177/107327481502200313

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  6 in total

Review 1.  Total robotic pancreaticoduodenectomy: a systematic review of the literature.

Authors:  Michail Kornaropoulos; Demetrios Moris; Eliza W Beal; Marinos C Makris; Apostolos Mitrousias; Athanasios Petrou; Evangelos Felekouras; Adamantios Michalinos; Michail Vailas; Dimitrios Schizas; Alexandros Papalampros
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

2.  Robotic-Assisted Versus Laparoscopic Colectomy Results in Increased Operative Time Without Improved Perioperative Outcomes.

Authors:  Brian Ezekian; Zhifei Sun; Mohamed A Adam; Jina Kim; Megan C Turner; Brian F Gilmore; Cecilia T Ong; Christopher R Mantyh; John Migaly
Journal:  J Gastrointest Surg       Date:  2016-03-10       Impact factor: 3.452

3.  Perioperative Outcomes of Robotic Pancreaticoduodenectomy: a Propensity-Matched Analysis to Open and Laparoscopic Pancreaticoduodenectomy.

Authors:  A Floortje van Oosten; Ding Ding; Joseph R Habib; Ahmer Irfan; Ryan K Schmocker; Elisabetta Sereni; Benedict Kinny-Köster; Michael Wright; Vincent P Groot; I Quintus Molenaar; John L Cameron; Martin Makary; Richard A Burkhart; William R Burns; Christopher L Wolfgang; Jin He
Journal:  J Gastrointest Surg       Date:  2020-11-17       Impact factor: 3.452

4.  Robotic pancreaticoduodenectomy.

Authors:  Richard Sola; Russell C Kirks; David A Iannitti; Dionisios Vrochides; John B Martinie
Journal:  J Vis Surg       Date:  2016-07-26

Review 5.  Minimally invasive pancreaticoduodenectomy for periampullary disease: a comprehensive review of literature and meta-analysis of outcomes compared with open surgery.

Authors:  Ke Chen; Yu Pan; Xiao-Long Liu; Guang-Yi Jiang; Di Wu; Hendi Maher; Xiu-Jun Cai
Journal:  BMC Gastroenterol       Date:  2017-11-23       Impact factor: 3.067

6.  Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel Response.

Authors:  Judith Pape; Katerina Stamati; Rawiya Al Hosni; Ijeoma F Uchegbu; Andreas G Schatzlein; Marilena Loizidou; Mark Emberton; Umber Cheema
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.